Frankfurt am Main, Germany

Rolf H Orlein


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf H. Orlein: A Pioneer in Pharmaceutical Innovations

Introduction

Rolf H. Orlein, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Orlein's work focuses on the development of innovative compounds that have the potential to transform medical treatments.

Latest Patents

Among his latest patents are novel diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate, specifically designed to be enterally absorbable. These diastereomers include (6R, 7R)-7-[2-(2-aminothiazol-4-yl)-2-(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate. The patents detail both the compounds of the formula I and their physiologically acceptable salts, as well as diastereomerically pure salts of these compounds. The preparation process includes a method for precipitating different diastereomers through careful mixing and filtration, allowing for the selective isolation of desired compounds.

Career Highlights

Rolf H. Orlein's career is highlighted by his tenure at Hoechst Aktiengesellschaft, where he has collaborated on numerous groundbreaking projects aimed at enhancing drug efficacy. His inventive approach and dedication to pharmaceutical science have positioned him as a noteworthy figure in the industry.

Collaborations

Orlein's work has been enriched by collaborations with esteemed colleagues such as Gerd Fischer and Uwe Gerlach. These partnerships have fostered an environment of innovation, contributing to the advancement of pharmaceutical formulations and therapeutic solutions.

Conclusion

In conclusion, Rolf H. Orlein is a distinguished inventor whose contributions to pharmaceutical innovations are evidenced by his patents. His ongoing work at Hoechst Aktiengesellschaft and collaborative efforts with fellow inventors reflect a robust commitment to improving public health through scientific advancement. His legacy continues to inspire future generations in the field of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…